Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

In vivo single cell tracking of progenitor cells labeled with nanowire lasers using optical coherence tomography and fluorescence microscopy dual-modality imaging

Nanowire lasers as intracellular probes.

In Vivo Tracking of Individual Stem Cells Labeled with Nanowire Lasers Using Multimodality Imaging.

Optical Coherence Tomography and Fluorescence Microscopy Dual-Modality Imaging for in Vivo Single-Cell Tracking with Nanowire Lasers.

Photostable Fluorescent Organic Dots with Aggregation-Induced Emission (aie Dots) for Noninvasive Long-Term Cell Tracing

Optical Neuronal Guidance

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Assessing in Vitro Stem‐cell Function and Tracking Engraftment of Stem Cells in Ischaemic Hearts by Using Novel Irfp Gene Labelling

Tracking Transplanted Cells in Live Animal Using Upconversion Fluorescent Nanoparticles

In Vivo Subretinal ARPE-19 Cell Tracking Using Indocyanine Green Contrast-Enhanced Multimodality Photoacoustic Microscopy, Optical Coherence Tomography, and Fluorescence Imaging for Regenerative Medicine

Multimodal High-Resolution Imaging of Photoreceptor Precursor Cells Using Gold Nanoparticles

Percutaneous Optical Imaging System to Track Reporter Gene Expression from Vasculatures in Vivo

Revealing the Fate of Transplanted Stem Cells In Vivo with a Novel Optical Imaging Strategy.

Long-term monitoring of intravital biological processes using fluorescent protein-assisted NIR-II imaging

Two-Photon Image Tracking of Neural Stem Cells via Iridium Complexes Encapsulated in Polymeric Nanospheres

Nanowire arrays restore vision in blind mice

Stem Cell Tracking with Optically Active Nanoparticles.

Amplification of Near-Infrared Fluorescence in Semiconducting Polymer Nanoprobe for Grasping the Behaviors of Systemically Administered Endothelial Cells in Ischemia Treatment

Differential Responses of Transplanted Stem Cells to Diseased Environment Unveiled by a Molecular NIR-II Cell Tracker

Photostimulable Near-Infrared Persistent Luminescent Nanoprobes for Ultrasensitive and Longitudinal Deep-Tissue Bio-Imaging.

Longitudinal Magnetic Resonance Imaging Tracking of Transplanted Neural Progenitor Cells in the Spinal Cord Utilizing the Bright-Ferritin Mechanism